Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2025-12-24 @ 7:13 PM
NCT ID:
NCT04510103
Eligibility Criteria:
Inclusion Criteria:
* moderately to severely dry skin on both leg legs, as determined by the investigator.
* Fitzpatrick skin types I-IV
* generally in good health
* routinely uses moisturizers on the legs at least 1-3 times per week.
* if of reproductive potential: using a medically acceptable form of birth control for at least 3 months before the study and willing to continue it for at least 1 month after study completion.
* able to read, write, speak, and understand English.
* willing and able to complete all study instructions.
* has completed the informed consent document including a HIPAA disclosure and photograph release.
Exclusion Criteria:
* known allergies/sensitivities to adhesive tapes or study product ingredients.
* known skin conditions, uncontrolled medical conditions, or any other condition that could interfere with evaluations/data interpretation or increase risk to the subject.
* any active bacterial/fungal/viral skin infections or susceptibility to such infections.
* females who are pregnant, breastfeeding, or planning to become pregnant in near future.
* compromised/broken skin, tattoos, scarring, excessive hair growth, very uneven skin tone, or other conditions that would interfere with evaluations or increase risk to the subject.
* current participation in another study.
* participation in another study in past 4 weeks.
* employees or relatives of the investigator or study site.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Maximum Age:
65 Years
Study:
NCT04510103
Study Brief:
Protocol Section:
NCT04510103